SCHEMBL228301

SCHEMBL228301

CCCC(O)C(CC)COCl

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5702884 0.82 LMNA (0.60) LMNA
SCHEMBL531016 0.80 LMNA (0.58) LMNA
SCHEMBL27908002 0.78 LMNA (0.56) LMNA
SCHEMBL5556231 0.78 LMNA (0.75) LMNA
SCHEMBL28374152 0.77 LMNA (0.54) LMNA
SCHEMBL28842615 0.77 LMNA (0.54) LMNA
SCHEMBL20298310 0.76 LMNA (0.71) LMNA
SCHEMBL14849495 0.74 LMNA (0.50) LMNA
SCHEMBL8478306 0.74 LMNA (0.50) LMNA
SCHEMBL8478301 0.74 LMNA (0.50) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004470-A1 PROCESS FOR PRODUCING ETHER COMPOUND KAO CORPORATION (JP) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004470-A1 PROCESS FOR PRODUCING ETHER COMPOUND CYP4F11, CYP4A11, RPS14 LMNA 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.